Skip Nav Destination
Issues
1 June 2013
-
Cover Image
Cover Image
Killian and colleagues found that gastrointestinal stromal tumors (GIST) with mutations in succinate dehydrogenase (SDH) complex genes exhibited a distinct methylation signature relative to the profile of KIT-mutant tumors and normal reference tissues. This methyldivergent profile was distinguished by increased global DNA hypermethylation, particularly at DNase hypersensitive sites, and was also present in other SDH-mutant tumor lineages, including paraganglioma and pheochromocytoma, supporting the oncogenotype dependence of this signature. In addition, a similarly perturbed methylation profile was detected in gliomas harboring mutations in another Krebs cycle enzyme, isocitrate dehydrogenase (IDH). These findings identify a strong association between the mitochondrial Krebs cycle and cancer epigenomic reprogramming. For details, please see the article by Killian and colleagues on page 648. - PDF Icon PDF LinkTable of Contents
ISSN 2159-8274
EISSN 2159-8290
Issue Sections
In This Issue
In the Spotlight
Review
Research Briefs
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Yi-Mi Wu; Fengyun Su; Shanker Kalyana-Sundaram; Nickolay Khazanov; Bushra Ateeq; Xuhong Cao; Robert J. Lonigro; Pankaj Vats; Rui Wang; Su-Fang Lin; Ann-Joy Cheng; Lakshmi P. Kunju; Javed Siddiqui; Scott A. Tomlins; Peter Wyngaard; Seth Sadis; Sameek Roychowdhury; Maha H. Hussain; Felix Y. Feng; Mark M. Zalupski; Moshe Talpaz; Kenneth J. Pienta; Daniel R. Rhodes; Dan R. Robinson; Arul M. Chinnaiyan
Author Choice
Succinate Dehydrogenase Mutation Underlies Global Epigenomic Divergence in Gastrointestinal Stromal Tumor
J. Keith Killian; Su Young Kim; Markku Miettinen; Carly Smith; Maria Merino; Maria Tsokos; Martha Quezado; William I. Smith, Jr; Mona S. Jahromi; Paraskevi Xekouki; Eva Szarek; Robert L. Walker; Jerzy Lasota; Mark Raffeld; Brandy Klotzle; Zengfeng Wang; Laura Jones; Yuelin Zhu; Yonghong Wang; Joshua J. Waterfall; Maureen J. O'Sullivan; Marina Bibikova; Karel Pacak; Constantine Stratakis; Katherine A. Janeway; Joshua D. Schiffman; Jian-Bing Fan; Lee Helman; Paul S. Meltzer
Research Articles
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
Alberto Bardelli; Simona Corso; Andrea Bertotti; Sebastijan Hobor; Emanuele Valtorta; Giulia Siravegna; Andrea Sartore-Bianchi; Elisa Scala; Andrea Cassingena; Davide Zecchin; Maria Apicella; Giorgia Migliardi; Francesco Galimi; Calogero Lauricella; Carlo Zanon; Timothy Perera; Silvio Veronese; Giorgio Corti; Alessio Amatu; Marcello Gambacorta; Luis A. Diaz, Jr; Mark Sausen; Victor E. Velculescu; Paolo Comoglio; Livio Trusolino; Federica Di Nicolantonio; Silvia Giordano; Salvatore Siena
Author Choice
Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
Adrienne L. Watson; Eric P. Rahrmann; Branden S. Moriarity; Kwangmin Choi; Caitlin B. Conboy; Andrew D. Greeley; Amanda L. Halfond; Leah K. Anderson; Brian R. Wahl; Vincent W. Keng; Anthony E. Rizzardi; Colleen L. Forster; Margaret H. Collins; Aaron L. Sarver; Margaret R. Wallace; Stephen C. Schmechel; Nancy Ratner; David A. Largaespada
News in Brief
News in Depth
Research Watch
Apoptosis
Biomarkers
Clinical Trials
DNA Repair
Glioma
Immunology
Immunotherapy
Lung Cancer
Melanoma
Metabolism
microRNA
Prostate Cancer
Signaling
Stem Cells
Structural Biology
Targeted Therapy
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.